BDBM708494 3-(5-((3-(((1r,3r, 5r,7r)-adamantan-2- yl)amino)propyl) amino)-2-methyl-4- oxoquinazolin- 3(4H)-yl)piperidine- 2,6-dione::US20240425475, Compound GT-02326

SMILES Cc1nc2cccc(NCCCNC3C4CC5CC(C4)CC3C5)c2c(=O)n1C1CCC(=O)NC1=O

InChI Key InChIKey=BQVFLLJKKFVPGU-UHFFFAOYSA-N

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 708494   

TargetProtein cereblon(Human)
Gluetacs Therapeutics (Shanghai) Co.

US Patent
LigandPNGBDBM708494(3-(5-((3-(((1r,3r, 5r,7r)-adamantan-2- yl)amino)pr...)
Affinity DataIC50: 700nMAssay Description:1. According to the instructions of the CEREBLON BINDING kits, the compounds to be tested of the present invention and lenalidomide were serially dil...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/7/2025
Entry Details
US Patent